Author:
Apostolakis Michael,Bettendorf Gerhard,Voigt Klaus D.
Abstract
ABSTRACT
Gonadotrophin extracted from human hypophyses (HHG) was administered in clinical trials to 5 amenorrhoic women. Gonadotrophin levels in the blood and urine and the urinary excretion of oestrogen, pregnanediol, 17-hydroxycorticosteroids, 17-ketosteroids and pregnanetriol were determined before, during and after treatment. Clinical control methods included endometrial biopsy and vaginal smear examination. Following the i. m. administration of HHG the gonadotrophin excretion increased markedly within the first 24 hours. Plasma gonadotrophin increased to substantially higher levels within 4–6 hours after the first injection. After cessation of treatment both plasma and urine gonadotrophin concentration returned slowly within 2–4 days to the pre-treatment levels. Following treatment, all 4 patients with hypogonadotrophic amenorrhoea (primary pituitary insufficiency) responded by an increased oestrogen and pregnanediol production. It would seem therefore that HHG-treatment had succeeded in producing ovulation. The single case of hypergonadotrophic amenorrhoea (primary ovarian insufficiency) showed no response in this respect. No change in 17-OHCS excretion was effected by the HHG-treatment. Changes in 17-ketosteroids and pregnanetriol excretion did not show a constant pattern. The clinical effects obtained in the 4 hypogonadotrophic amenorrhoea cases are confirmed in that ovulation was induced by means of the treatment.
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献